Correspondence 0001493152-23-008027 from MANGOCEUTICALS, INC. (MGRX)

MANGOCEUTICALS, INC.
Date: March 17, 2023 · CIK: 0001938046 · Accession: 0001493152-23-008027

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269240

Date

March 14, 2023

Author

Securities, LLC

Form

CORRESP

Company

MANGOCEUTICALS, INC.

Letter

Re: Withdrawal of Acceleration Request of Mangoceuticals, Inc.

March 17, 2023

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

F Street, NE

Washington, DC 20549

Attn: Office of Industrial Applications and Services

Registration Statement on Form S-1

File No. 333-269240

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on March 14, 2023, in which we, as representative of the several underwriters of Mangoceuticals, Inc.’s proposed public offering, joined Mangoceuticals, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for 5:00 p.m. Eastern time on Thursday, March 16, 2023, or as soon thereafter as practicable. Mangoceuticals, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

[Signature page follows]

Very
truly yours,
Boustead
Securities, LLC

Show Raw Text

CORRESP
1
filename1.htm

March
17, 2023

VIA
EDGAR

Division
of Corporation Finance

U.S.
Securities & Exchange Commission

100
F Street, NE

Washington,
DC 20549

Attn:
Office of Industrial Applications and Services

Re: Withdrawal
                                            of Acceleration Request of Mangoceuticals, Inc.

  Registration
                                            Statement on Form S-1

  File
                                            No. 333-269240

Ladies
and Gentlemen:

Reference
is made to our letter, filed as correspondence via EDGAR on March 14, 2023, in which we, as representative of the several underwriters
of Mangoceuticals, Inc.’s proposed public offering, joined Mangoceuticals, Inc.’s request for acceleration of the effective
date of the above-referenced Registration Statement for 5:00 p.m. Eastern time on Thursday, March 16, 2023, or as soon thereafter as
practicable. Mangoceuticals, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we
hereby formally withdraw our request for acceleration of the effective date.

[Signature
page follows]

Very
truly yours,

    Boustead
    Securities, LLC

    By:
    /s/
    Keith Moore

    Name:
    Keith
    Moore

    Title:
    CEO

    As
    representative of the underwriters

SecProbe.io